Bariatric Times

Insights into Patient Pop with Obesity 2016

A peer-reviewed, evidence-based journal that promotes clinical development and metabolic insights in total bariatric patient care for the healthcare professional

Issue link:

Contents of this Issue


Page 25 of 26

C26 Bariatric Times • December 2016 • Supplement C Rev. 2013;14(11):871–882. 30. Vink R, Roumans N, Fazelzadeh P, et al. Adipose tissue gene expression is differentially r egulated with different rates of weight loss in overweight and obese humans. Int J Obes (Lond). 2016 Dec 7. [Epub ahead of print]. 31. Casanello P, Krause B, Castro- Rodriguez J, Uauy R. [Epigenetics and obesity]. Revista chilena de pediatria. 2016;87(5):335–342. 32. Goni L, Cuervo M, Milagro F, M artinez J. Future perspectives of personalized weight loss interventions based on nutrigenetic, epigenetic, and metagenomic data. J Nutr. 2016 Mar 9. [Epub ahead of print]. 33. Ceperuelo-Mallafre V, Ejarque M, Serena C, et al. Adipose tissue glycogen accumulation is associated with obesity-linked inflammation in humans. Mol Metab. 2015;5(1):5–18. 34. Bray M, Loos R, McCaffery J, et al. NIH working group report-using genomic information to guide weight management: from universal to precision treatment. Obesity (Silver Spring). 2016;24(1):14–22. 35. Meisel S, Beeken R, van Jaarsveld C, Wardle J. Genetic susceptibility testing and readiness to control weight: results from a randomized controlled trial. Obesity (Silver Spring). 2015;23(2):305–312. 36. Fu S, Ping P, Luo L, Ye P. Deep analyses of the associations of a series of biomarkers with insulin resistance, metabolic syndrome, and diabetes risk in nondiabetic middle-aged and elderly indivudals: results from a Chinese community-based study. Clinical Interventions in Aging. 2016;11:1531-1538. 37. Martinez K, Pierre J, Chang E. The gut microbiota: the gateway to improved metabolism. Gastroenterol Clin North Am. 2016;45(4):601–614. 38. Cruz-Monserrate Z, Conwell D, Krishna S. The impact of obesity on gallstone disease, acute pancreatitis, and pancreatic cancer. Gastroenterol Clin North Am. 2016;45(4):625–637. 39. Jordani P, Campbi L, Circeli G, Visscher C, Bigar M, Goncalves D. Obesity as a risk factor for temporomandibular disorders. J O ral Rehabil. 2016 Oct 17. [Epub ahead of print] 40. Allen S, Dal Grande E, Abernethy A, Currow D. Two colliding epidemics-obesity is independently associated with chronic pain interfering with activities of daily living in adults 18 years and over; a cross- s ecxtional population-based study. BMC Public Health. 2016;16(1):1034. 41. Collins J, Meng C, Eng A. Psychological impact of severe obesity. Curr Obes Rep. 2016;5(4):435–440. 42. Shieh C, Knisely M, Clark DB, Carpenter J. Self-weighing in weight management interventions: a systematic review of literature. Obes Res Clin Pract. 2016;10(5):493–519. 43. de Vries H, Kooiman T, van Ittersum M, van Brussel M, de Groot M. Do activity monitors increase physical activity in adults with overweight or obesity? A systematic review and meta- analysis. Obesity (Silver Spring). 2016;24(10):2078–2091. 44. Department of Health and Human Services. Intensive Behavioral Therapy (IBT) for Obesity. 2011; and-Education/Medicare-Learnin g-Network- MLN/MLNMattersArticles/down loads/MM7641.pdf. Accessed November 16, 2016. 45. Vallis M, Piccinini-Vallis H, Sharma A, Freedhoff Y. Clinical review: modified 5As: minimal intervention for obesity counseling in primary care. Can Fam Physician. 2013;59(1):27–31. 46. Meriwether R, Lee J, Lafleur A, Wiseman P. Physical activity counseling. Am Fam Physician. 2008;77(8):1129–1136. 47. Kahan S, Zvenyach T. Obesity as a disease: current policies and implications for the future. Curr Obes Rep. 2016;5(2):291–297. 48. Lazo M, Solga S, Horska A, et al. Effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes. Diabetes Care. 2010;33(10):2156-2163. 4 9. Phelan S, Kanaya A, Subak L, et al. Weight loss prevents urinary incontinence in women with type 2 diabetes: results from the Look AHEAD trial. J Urol. 2012;187(3):939–944. 50. Wing R, Bond D, Gendrano Ir, et al. Effect of intensive lifestyle intervention on sexual dysfunction i n women with type 2 diabetes: results from an ancillary Look AHEAD study. Diabetes Care. 2013;36(10):2937–2944. 51. Wing R, Rosen R, FAVA J, et al.. Effects of weight loss intervention on erectile function in order men with type 2 diabetes in the Look AHEAD trial. J Sex Med. 2010;7(1 Pt 1):156–165. 52. Kolotkin R. Impact of Weight on Quality of Life-Lite (IWQOL-Lite). Quality of Life Consulting 2016; m/iwqol-lite.html. Accessed November 16, 2016. 53. Promrat K, Kleiner D, Niemeier H, et al. Randomized controlled trial testing the effects of weight loss on nonalcholic steatohepatitis. Hepatology. 2010;51(1):121–129. 54. Foster G, Borradaile K, Sanders M, et al. A randomized study of the effect of weight loss on obstructive sleep apnea among obese patients with type 2 diabetes: the Sleep AHEAD Study. Arch Intern Med. 2009;169(17):1619–1626. 55. Despres J, Lemieux I, Prud'homme D. Treatment of obesity: need to focus on high risk abdominally obese patients. BMJ. 2001;322(7288):716–720. Insights into the Patient Population with Obesity: Assessment and Treatment u

Articles in this issue

Links on this page

Archives of this issue

view archives of Bariatric Times - Insights into Patient Pop with Obesity 2016